The Joint Commission’s updated accreditation manual is designed to simplify requirements, enhance clarity, and better support healthcare organizations in survey preparation. In this episode of VerifiedRx, host Carolyn Liptak is joined by Dr. Robert Campbell of the Joint Commission and Diana Scott of Vizient to unpack the most significant changes. From the shift to National Performance Goals and medication safety priorities to the latest challenges in compounding, labeling, and hazardous drug handling, the conversation highlights practical insights to help pharmacy leaders stay compliant and survey-ready.

Guest speakers:

Robert Campbell, PharmD, BCSCP

Sr. Director, Standards Interpretation, Accreditation Decision Management,Medication Safety Division of Accreditation and Certification Operations

Joint Commission

Diana Scott, MHA, RN, CPHQ

Principal, Regulatory and Accreditation Services

Vizient

Host:

Carolyn Liptak, , BS Pharm, MBA 

Vizient

Show Notes:

[01:16-01:51] Diana and Robert Backgrounds

[01:52-02:43] Changes made to the hospital and critical access hospital manuals

[02:44-03:09] Changes to the chapters themselves

[03:10-04:08] National Performance Goals and elaborate on those that are relevant to medication safety and pharmacy services

[04:09-05:15] The top medication management challenges

[05:16-06:29] Pain management not being aligned and titration orders

[06:30-06:56] Insufficient communication between pharmacists, prescribers and nurses when it comes to medication orders

[06:57-08:02] Themes around labeling requirements for stored medications

[08:03-08:46] Anything different in removing expired meds from patient care areas and in the pharmacy this area than previous years

[08:47-10:58] Issues related to storing meds specifically per the package insert

[10:59-11:55] Common issues seen inside the pharmacy regarding sterile compounding, noncompliance include hand hygiene, garbing, PPE, and cleaning and disinfecting

[11:56-13:12] More specifics in those area the physical environment and facility cleanliness along with cleaning and disinfection practices

[13:13-14:55] Explaination of how joint Commission defines and evaluates immediate use compounding

[14:56-16:09] The minimum required elements for immediate use compounding competency

[16:10-17:12] Compounding competencies besides immediate use

[17:13-17:54] Expectations for environmental services training

[17:55- 20:14] Concerns around hazardous drugs

[20:15- 21:14] Additional information

Links | Resources:

Joint Commission: THE NEW STANDARD: Accreditation 360

Subscribe Today!

Apple Podcasts

Spotify

YouTube

RSS Feed

Drug diversion threatens patient and staff safety—and preventing it requires a coordinated, multidisciplinary approach. In this episode, Dr. Ruth Igwegbe and Shealee Mitchell of JPS Health Network join host Carolyn Liptak to share how their organization transformed a fragmented diversion process into a high-functioning, collaborative program. From building trust with frontline teams to using AI software and proactive data monitoring, Ruth and Shealee highlight how culture, consistency, and communication are essential to effective diversion prevention. Tune in for actionable strategies that elevate both patient safety and professional accountability.

Guest speakers:

Dr. Ruth Igwegbe PharmD, MBA,

Pharmacy medication safety officer

JPS Health Network

Shealee Mitchell, BS, RN, MJur

Pharmacy medication safety officer

JPS Health Network

Host:

Carolyn Liptak, BS Pharm, MBA 

Vizient

Show Notes:

[01:02-02:32] Ruth and Shealee Backgrounds

[02:33-04:46] Background on diversion detection and prevention program at JPS

[04:47-06:55] Shealee's clinical background and how it shaped how she works with teams across the organization

[06:56-09:20] How the JPS diversion response team evolved

[09:21-13:55] Advice to our listeners to strengthen their own diversion prevention programs

[13:56-16:03] Where our listeners should go to get more information about drug diversion prevention and detection programs

Subscribe Today!

Apple Podcasts

Spotify

YouTube

RSS Feed

The Vizient Summer 2025 Spend Management Outlook (SMO) provides an integrated perspective on trends, factors and future expenses providers will face across the various dimensions of healthcare. In this episode, Dr. Carina Dolan and Dr. Jeni Hayes join host Carolyn Liptak to discuss pharmacy insights from the SMO including declining drug price inflation and how autoimmune conditions have surpassed oncology in total pharmacy costs. They also touch on pediatric spend drivers, biosimilar competition, and the impact of novel therapies. Tune in to VerifiedRx for practical insights to help pharmacy leaders plan for what’s ahead.

Guest speakers:

Carina Dolan, Pharm. D., MS Pharm, BCOP Associate Vice President, Clinical Oncology, Pharmacoeconomics and Market Insights Vizient Jeni Hayes, PharmD, MS Pharm, BCPS Senior Clinical Manager, Market Intelligence Vizient  Host:  Carolyn Liptak, BS Pharm, MBA VerifiedRx Host

Show Notes:

[01:13-02:41] Key pharmacy trends emerging from the Summer SMO

[02:42-04:00] Current pharmacy trends

[04:01-05:55] Pharmacy spend for autoimmune conditions has exceeded that of oncology

[05:56-07:36] Key takeaways

[07:37-08:47] Significant trends in this latest therapeutic insights update

[08:48-10:04] Challenges in gene and cell therapy space

[10:05-11:33] The Therapeutic Insights webpage for pediatrics

[11:34-13:41] Other reflections from the SMO

[13:42-14:49] How to locate the SMO

Links | Resources:

Vizient Spend Management Outlook

Vizient Therapeutic class insights

Subscribe Today!

Apple Podcasts

Amazon Podcasts

Spotify

Android

RSS Feed